20 Hrs
Source:
الاقتصادية
Sadeer Pharma invests 200M riyals in biopharmaceuticals and cancer drugs
Saudi Sedir Pharma Company plans to invest 200 million Saudi Riyals to develop four production lines aimed at localizing biopharmaceuticals in Saudi Arabia, including the local manufacturing of six biopharmaceutical products. The company has begun the second phase of its insulin localization project, with new products expected to be launched in the market next year following the arrival of the equipment. Currently, the company is focusing on manufacturing more than 40 products for cancer treatments, which are exported to six countries. These efforts are part of a broader initiative to enhance drug security and increase the availability of medicines locally at affordable prices, with future plans to expand exports.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)